Cite
Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies.
MLA
Bravo-Gonzalez, Andres, et al. “Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies.” Cancers, vol. 16, no. 20, Oct. 2024, p. 3434. EBSCOhost, https://doi.org/10.3390/cancers16203434.
APA
Bravo-Gonzalez, A., Alasfour, M., Soong, D., Noy, J., & Pongas, G. (2024). Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies. Cancers, 16(20), 3434. https://doi.org/10.3390/cancers16203434
Chicago
Bravo-Gonzalez, Andres, Maryam Alasfour, Deborah Soong, Jose Noy, and Georgios Pongas. 2024. “Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies.” Cancers 16 (20): 3434. doi:10.3390/cancers16203434.